Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
Introduction Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD b...
Saved in:
Published in | Dermatology and therapy Vol. 12; no. 12; pp. 2653 - 2668 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cheshire
Springer Healthcare
01.12.2022
Springer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents.
Methods
A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL).
Results
Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually.
Conclusions
The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics.
Plain Language Summary
Atopic dermatitis is a very common skin disease among children and adults. The disease is nonfatal but may lead to patients and families having a low quality of life and decreased productivity, especially in its severe state. Because atopic dermatitis is more common in children than adults, most published research is directed to studying the effect of the disease on children. Atopic dermatitis affects patients’ health, quality of life, financial state, and productivity. Therefore, our study aims to study and quantify the burden caused by the disease represented in the clinical burden, humanistic burden, and economic burden. We conducted a systematic literature review to determine all relevant studies providing specific values for the burden. The studies included are those providing information on the percentage of patients affected by specific symptoms, costs paid for treatment, number of days of productivity lost due to the disease, and quality-of-life questionnaire results for patients with atopic dermatitis or their caregivers. We analyzed the data from all relevant studies to calculate average values and quantify the burden. The results of our study should help healthcare sector decision-makers in understanding the real effect of the disease on adults and adolescents and rearrange their priorities for treating different diseases based on the specific burden of each disease. |
---|---|
AbstractList | Although previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. Atopic dermatitis is a very common skin disease among children and adults. The disease is nonfatal but may lead to patients and families having a low quality of life and decreased productivity, especially in its severe state. Because atopic dermatitis is more common in children than adults, most published research is directed to studying the effect of the disease on children. Atopic dermatitis affects patients’ health, quality of life, financial state, and productivity. Therefore, our study aims to study and quantify the burden caused by the disease represented in the clinical burden, humanistic burden, and economic burden. We conducted a systematic literature review to determine all relevant studies providing specific values for the burden. The studies included are those providing information on the percentage of patients affected by specific symptoms, costs paid for treatment, number of days of productivity lost due to the disease, and quality-of-life questionnaire results for patients with atopic dermatitis or their caregivers. We analyzed the data from all relevant studies to calculate average values and quantify the burden. The results of our study should help healthcare sector decision-makers in understanding the real effect of the disease on adults and adolescents and rearrange their priorities for treating different diseases based on the specific burden of each disease. Introduction Although previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. Methods A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). Results Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. Conclusions The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. Introduction Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. Methods A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). Results Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. Conclusions The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. Plain Language Summary Atopic dermatitis is a very common skin disease among children and adults. The disease is nonfatal but may lead to patients and families having a low quality of life and decreased productivity, especially in its severe state. Because atopic dermatitis is more common in children than adults, most published research is directed to studying the effect of the disease on children. Atopic dermatitis affects patients’ health, quality of life, financial state, and productivity. Therefore, our study aims to study and quantify the burden caused by the disease represented in the clinical burden, humanistic burden, and economic burden. We conducted a systematic literature review to determine all relevant studies providing specific values for the burden. The studies included are those providing information on the percentage of patients affected by specific symptoms, costs paid for treatment, number of days of productivity lost due to the disease, and quality-of-life questionnaire results for patients with atopic dermatitis or their caregivers. We analyzed the data from all relevant studies to calculate average values and quantify the burden. The results of our study should help healthcare sector decision-makers in understanding the real effect of the disease on adults and adolescents and rearrange their priorities for treating different diseases based on the specific burden of each disease. INTRODUCTIONAlthough previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. METHODSA systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). RESULTSAmong 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. CONCLUSIONSThe burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. |
Audience | Academic |
Author | Korra, Nada Aderian, Sandrine Abaza, Sherif Fasseeh, Ahmad N. Tannira, Mohamed Kaló, Zoltán Dalle, Hala Elezbawy, Baher |
Author_xml | – sequence: 1 givenname: Ahmad N. orcidid: 0000-0001-9878-7734 surname: Fasseeh fullname: Fasseeh, Ahmad N. organization: Syreon Middle East, Faculty of Pharmacy, Alexandria University – sequence: 2 givenname: Baher orcidid: 0000-0003-1335-9285 surname: Elezbawy fullname: Elezbawy, Baher email: baher.elezbawy@syreon.eu organization: Syreon Middle East – sequence: 3 givenname: Nada orcidid: 0000-0003-0611-3789 surname: Korra fullname: Korra, Nada organization: Syreon Middle East – sequence: 4 givenname: Mohamed surname: Tannira fullname: Tannira, Mohamed organization: AbbVie BioPharmaceuticals – sequence: 5 givenname: Hala surname: Dalle fullname: Dalle, Hala organization: AbbVie BioPharmaceuticals – sequence: 6 givenname: Sandrine surname: Aderian fullname: Aderian, Sandrine organization: AbbVie BioPharmaceuticals – sequence: 7 givenname: Sherif orcidid: 0000-0002-7049-0637 surname: Abaza fullname: Abaza, Sherif organization: Syreon Middle East – sequence: 8 givenname: Zoltán orcidid: 0000-0001-7762-2607 surname: Kaló fullname: Kaló, Zoltán organization: Center for Health Technology Assessment, Semmelweis University, Syreon Research Institute |
BookMark | eNp9UV1rHCEUlZLSpNv8gT4JfenLpFfnw7EPhU36CQuFtnkWR-9sDbO6VScl_75OJhQCpQp6uZ5zON7znJz44JGQlwwuGIB4k1jdtm0FnFcAPZNV94SccSahkkzwk_u6rnrO4JScp3QDZQno6p49I6d1x6Roe3lGri_naNHTMNJtDkdn6HuMB51ddok6T7d2nnKi2ttShgmTQZ_TW6rp97uUcUEaunMZo85zRPoNbx3-fkGejnpKeP5wb8j1xw8_rj5Xu6-fvlxtd5VpJOSqATHyZqhHi0ZAYxjv2tIyzLR1x4fa2MH2hqPsBobQI7B2ZFaC7WrZ9eXckHer7nEeDmgXb1FP6hjdQcc7FbRTj1-8-6n24VbJTjQ9WwRePwjE8GvGlNXBlS9Ok_YY5qS44AUlZZnlhrxaoXs9oXJ-DEXRLHC1FVxA33IJBXXxD1TZFg_OlAhHV_qPCHwlmBhSijj-dc9ALUmrNWlVklb3SavFdr2SUgH7PUZ1E-boy6j_x_oDSdCq9g |
CitedBy_id | crossref_primary_10_1007_s11136_023_03519_6 crossref_primary_10_1016_j_anai_2024_06_010 crossref_primary_10_1089_derm_2023_0176 crossref_primary_10_4103_am_am_210_22 crossref_primary_10_1111_exd_15116 crossref_primary_10_3390_cimb46030143 crossref_primary_10_3389_fphar_2023_1220945 crossref_primary_10_3390_jcm12144675 crossref_primary_10_1080_09546634_2024_2376268 crossref_primary_10_36290_der_2023_018 crossref_primary_10_1016_j_intimp_2024_111706 crossref_primary_10_1111_pai_14181 crossref_primary_10_1002_jvc2_324 crossref_primary_10_2340_actadv_v104_18255 crossref_primary_10_3390_ijerph20031918 crossref_primary_10_1007_s13555_024_01185_1 crossref_primary_10_1080_13696998_2022_2152234 crossref_primary_10_30773_pi_2023_0018 crossref_primary_10_1177_23743735241231696 crossref_primary_10_1063_5_0136543 crossref_primary_10_3390_biom13071100 crossref_primary_10_1080_1744666X_2023_2283585 crossref_primary_10_1124_jpet_122_001469 crossref_primary_10_1016_j_vhri_2024_100987 crossref_primary_10_1007_s13555_024_01199_9 crossref_primary_10_2217_imt_2023_0066 crossref_primary_10_1007_s00403_024_03130_w crossref_primary_10_1080_09546634_2024_2324833 |
Cites_doi | 10.1111/dth.13606 10.1155/2016/2568301 10.1371/journal.pone.0171667 10.1111/1346-8138.14947 10.1016/j.jaad.2017.04.019 10.1111/jdv.15223 10.5021/ad.2015.27.3.298 10.2340/00015555-2797 10.3390/jcm4040535 10.1111/1346-8138.14116 10.1016/j.jval.2019.04.1836 10.1016/j.jaci.2020.12.001 10.1016/j.jaad.2017.08.002 10.1111/ajd.12632 10.1371/journal.pone.0182897 10.2340/00015555-3117 10.1097/MD.0000000000000949 10.1038/s41573-021-00266-6 10.1111/1346-8138.15366 10.1016/j.apnu.2017.06.001 10.2340/00015555-2221 10.1111/jdv.15634 10.2196/resprot.4134 10.1111/1346-8138.14787 10.1136/bmj.39489.470347.AD 10.2500/aap.2018.39.4175 10.2340/00015555-2741 10.1111/bjd.18451 10.1111/jdv.13689 10.1111/j.1365-2133.2011.10799.x 10.1111/jdv.12154 10.1007/s13555-020-00459-8 10.2340/00015555-3416 10.1007/s13555-020-00356-0 10.1684/ejd.2011.1560 10.2340/00015555-3065 10.1111/jdv.16078 10.1016/j.jval.2014.08.2042 10.1016/j.ad.2019.03.018 10.1253/circj.CJ-12-1371 10.1177/1203475418758992 10.1111/j.1600-0536.2012.02062.x 10.1016/j.anai.2019.07.008 10.1016/j.jval.2020.08.2024 10.1111/all.13085 10.1111/1346-8138.14218 10.2340/00015555-3653 10.1111/phpp.12479 10.1016/j.jval.2012.08.1791 10.2340/00015555-3212 10.1111/bjd.18920 10.1111/j.1468-3083.2012.04578.x 10.1097/DER.0000000000000517 10.1097/DER.0000000000000486 10.1016/j.jid.2020.03.961 10.1111/1346-8138.12220 10.1111/jdv.15919 10.1016/j.jaci.2007.11.004 10.1080/03007995.2016.1195733 10.1145/3025453.3025569 10.1111/bjd.19580 10.1016/j.jaip.2017.10.024 10.1016/j.jaci.2006.02.031 10.1097/DER.0000000000000602 10.1371/journal.pone.0249824 10.1111/bjd.18296 10.1016/j.anai.2019.12.002 10.18176/jiaci.0641 10.1097/01.EWX.0000503397.22746.bd 10.1016/j.jaad.2020.05.041 10.1136/bmj.n71 10.3390/jcm9030791 10.1097/DER.0000000000000161 10.1016/j.jval.2020.08.2025 10.1186/1471-2458-14-1196 10.1371/journal.pone.0134657 10.1111/jdv.15581 10.1016/j.jaad.2019.03.037 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 COPYRIGHT 2022 Springer |
Copyright_xml | – notice: The Author(s) 2022 – notice: COPYRIGHT 2022 Springer |
DBID | C6C AAYXX CITATION 7X8 5PM |
DOI | 10.1007/s13555-022-00819-6 |
DatabaseName | SpringerOpen CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2190-9172 |
EndPage | 2668 |
ExternalDocumentID | A727085290 10_1007_s13555_022_00819_6 |
GeographicLocations | Egypt |
GeographicLocations_xml | – name: Egypt |
GrantInformation_xml | – fundername: AbbVie Biotherapeutics funderid: http://dx.doi.org/10.13039/100010878 – fundername: ; |
GroupedDBID | --- -A0 0R~ 2VQ 3V. 4.4 40G 53G 5VS 7X7 8AO 8FI 8FJ AAKDD AAKKN AAPBV AAYZJ ABDBF ABUWG ACACY ACGFS ACMJI ADBBV ADINQ ADRAZ AFGXO AFKRA AFNRJ AHBXF AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BPHCQ BVXVI C24 C6C CCPQU DIK EBS EJD FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ IAO KQ8 LGEZI LOTEE M48 M~E NADUK NXXTH O9- OK1 PIMPY PQQKQ PROAC RNS RPM RSV SISQX SMD SOJ U2A UKHRP ~JE AAYXX ABEEZ ACULB CITATION ITC 7X8 5PM |
ID | FETCH-LOGICAL-c490t-407f24b3fdec704c126507fc1c5362b3cdbd8c2e96b1e08e015f1d90d63968d63 |
IEDL.DBID | RPM |
ISSN | 2193-8210 |
IngestDate | Tue Sep 17 21:35:10 EDT 2024 Sat Oct 05 05:27:23 EDT 2024 Thu Feb 22 23:50:58 EST 2024 Tue Nov 12 23:34:47 EST 2024 Thu Sep 26 15:47:43 EDT 2024 Sat Dec 16 12:05:23 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Clinical burden Economic burden Atopic dermatitis Dermatology Humanistic burden Burden of disease Atopic eczema Systematic literature review |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c490t-407f24b3fdec704c126507fc1c5362b3cdbd8c2e96b1e08e015f1d90d63968d63 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0001-7762-2607 0000-0001-9878-7734 0000-0003-0611-3789 0000-0003-1335-9285 0000-0002-7049-0637 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674816/ |
PMID | 36197589 |
PQID | 2721639919 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9674816 proquest_miscellaneous_2721639919 gale_infotracmisc_A727085290 gale_infotracacademiconefile_A727085290 crossref_primary_10_1007_s13555_022_00819_6 springer_journals_10_1007_s13555_022_00819_6 |
PublicationCentury | 2000 |
PublicationDate | 2022-12-01 |
PublicationDateYYYYMMDD | 2022-12-01 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cheshire |
PublicationPlace_xml | – name: Cheshire |
PublicationSubtitle | Research, treatment and aesthetic interventions in dermatology |
PublicationTitle | Dermatology and therapy |
PublicationTitleAbbrev | Dermatol Ther (Heidelb) |
PublicationYear | 2022 |
Publisher | Springer Healthcare Springer |
Publisher_xml | – name: Springer Healthcare – name: Springer |
References | Boehm, Schmid-Ott, Finkeldey, John, Dwinger, Werfel (CR43) 2012; 67 Eckert, Gupta, Gadkari, Mahajan, Gelfand (CR61) 2019; 81 Kwak, Kim (CR53) 2017; 31 Mina, Jabeen, Singh, Verma (CR54) 2015; 60 Grant, Seiding Larsen, Trennery, Silverberg, Abramovits, Simpson (CR16) 2019; 30 Ostermann, Witt, Reinhold (CR80) 2017; 12 Chrostowska-Plak, Reich, Szepietowski (CR44) 2013; 27 Igarashi, Fujita, Arima, Inoue, Dorey, Fukushima (CR51) 2019; 46 Silverberg, Lei, Yousaf, Janmohamed, Vakharia, Chopra (CR52) 2020; 83 Whiteley, Emir, Seitzman, Makinson (CR73) 2016; 32 Väkevä, Niemelä, Lauha, Pasternack, Hannuksela-Svahn, Hjerppe (CR48) 2019; 35 Devleesschauwer, Maertens de Noordhout, Smit, Duchateau, Dorny, Stein (CR8) 2014; 14 Misery, Seneschal, Reguiai, Merhand, Héas, Huet (CR27) 2019; 33 Zuberbier, Orlow, Paller, Taïeb, Allen, Hernanz-Hermosa (CR4) 2006; 118 Avena-Woods (CR18) 2017; 23 Heratizadeh, Haufe, Stölzl, Abraham, Heinrich, Kleinheinz (CR41) 2020; 34 Lin, Chu, Cho, Lee, Tsai, Tang (CR89) 2019; 22 Falissard, Simpson, Guttman-Yassky, Papp, Barbarot, Gadkari (CR33) 2020; 10 Schild, Weber, Galetzka, Enders, Zügel, Gothe (CR84) 2020; 23 Joish, Sullivan, Hartisch, Kamalakar, Eichenfield (CR82) 2012; 15 Mann, Dreher, Weess, Staubach (CR9) 2020; 100 Ostermann, Reinhold, Witt (CR81) 2015; 10 Torrelo, Ortiz, Alomar, Ros, Prieto, Cuervo (CR93) 2012; 22 Norrlid, Hjalte, Lundqvist, Svensson, Ragnarson (CR79) 2016; 96 Ring, Zink, Arents, Seitz, Mensing, Schielein (CR7) 2019; 33 Yano, Saeki, Ishiji, Ishiuji, Sato, Tofuku (CR91) 2013; 40 Girolomoni, Luger, Nosbaum, Gruben, Romero, Llamado (CR68) 2020; 11 Fukunaga, Okada, Konishi, Murashita, Koyama (CR13) 2013; 77 Andersen, Nyeland, Nyberg (CR24) 2020; 182 Le, Vo (CR83) 2019; 69 Lee, Lee, Lee, Lee, Lee, Park (CR26) 2018; 98 Kim, Park, Ahn, Kim, Li, Kim (CR88) 2015; 27 Sicras-Mainar, Navarro-Artieda, Carrillo (CR74) 2018; 109 Pedersen, Uddin, Saha, Darmstadt (CR10) 2021; 16 Egeberg, Andersen, Gislason, Skov, Thyssen (CR57) 2017; 72 Ariëns, Van Nimwegen, Shams, De Bruin, Van der Schaft, Van Os-Medendorp (CR72) 2019; 99 Mizara, Papadopoulos, McBride (CR63) 2012; 166 Katoh, Saeki, Kataoka, Etoh, Teramukai, Takagi (CR28) 2019; 46 Ameen, Rabe, Blanthorn-Hazell, Millward (CR30) 2020; 23 Andersen, Nyeland, Nyberg (CR94) 2020; 182 Guyatt, Oxman, Vist, Kunz, Falck-Ytter, Alonso-Coello (CR15) 2008; 336 Yu, Attarian, Zee, Silverberg (CR66) 2016; 27 Bobotsis, Fleming, Eshtiaghi, Cresswell-Melville, Drucker (CR67) 2018; 22 CR62 Nettis, Ferrucci, Ortoncelli, Pellacani, Foti, Di Leo (CR39) 2020; 32 Ezzedine, Shourick, Merhand, Sampogna, Taïeb (CR92) 2020; 100 Kim, Yim, Jo, Ahn, Seo, Choi (CR76) 2014; 17 van Os-Medendorp, Appelman-Noordermeer, Bruijnzeel-Koomen, de Bruin-Weller (CR90) 2015; 4 van Os-Medendorp, van Leent-de, de Bruin-Weller, Knulst (CR46) 2015; 4 Holm, Agner, Clausen, Thomsen (CR49) 2016; 30 Marron, Cebrian-Rodriguez, Alcalde-Herrero, Garcia-Latasa de Aranibar, Tomas-Aragones (CR11) 2020; 111 Ferrucci, Casazza, Angileri, Tavecchio, Germiniasi, Berti (CR36) 2020; 9 Napolitano, Fabbrocini, Scalvenzi, Nisticò, Dastoli, Patruno (CR47) 2020; 31 Reed, Blaiss (CR97) 2018; 39 Civelek, Sahiner, Yüksel, Boz, Orhan, Uner (CR64) 2011; 21 Langenbruch, Radtke, Franzke, Ring, Foelster-Holst, Augustin (CR65) 2014; 28 CR2 Kaaz, Szepietowski, Matusiak (CR45) 2019; 99 Laughter, Maymone, Mashayekhi, Arents, Karimkhani, Langan (CR1) 2021; 184 CR3 Ng, Tan, Chan, Foong, Koh (CR34) 2018; 59 Wang, Li, Zhao, Shen (CR35) 2016; 2016 CR87 CR86 CR85 Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow (CR12) 2021; 372 Eckert, Gupta, Amand, Gadkari, Mahajan, Gelfand (CR71) 2018; 78 Silverwood, Mansfield, Mulick, Wong, Schmidt, Roberts (CR19) 2021; 147 Shalom, Babaev, Kridin, Schonmann, Horev, Dreiher, Cohen (CR70) 2019; 99 Sheary, Harris (CR14) 2020; 31 Dieris-Hirche, Gieler, Petrak, Milch, Te Wildt, Dieris (CR50) 2017; 97 Le, Vo, Nguyen (CR25) 2019; 69 Heckman, Riley, Valdes-Rodriguez, Yosipovitch (CR40) 2020; 140 Sorour, Abdelmoaty, Bahary, El Birqdar (CR55) 2017; 14 CR17 Launois, Ezzedine, Cabout, Reguai, Merrhand, Heas (CR77) 2019; 33 Lei, Yousaf, Janmohamed, Vakharia, Chopra, Sacotte (CR38) 2020; 183 Bieber (CR95) 2022; 21 Murota, Inoue, Yoshida, Ishimoto (CR78) 2020; 47 Wei, Anderson, Gadkari, Blackburn, Moon, Piercy (CR69) 2018; 45 CR96 Chee, Branca, Jeker, Vogt, Schwegler, Navarini (CR32) 2020 Lei, Yousaf, Janmohamed, Vakharia, Chopra, Chavda (CR37) 2020; 124 Arima, Gupta, Gadkari, Hiragun, Kono, Katayama (CR59) 2018; 45 Drucker, Qureshi, Amand, Villeneuve, Gadkari, Chao (CR75) 2018; 6 Kim, Hur, Jang, Park, Hong, Son (CR58) 2015; 94 CR29 CR23 CR22 Wei, Ghorayeb, Andria, Walker, Schnitzer, Kennedy (CR42) 2019; 123 CR21 CR20 Williams, Stewart, von Mutius, Cookson, Anderson (CR6) 2008; 121 Wu, Lu, Lu, Su, Tsai, Wu (CR56) 2017; 12 Eckert, Gupta, Amand, Gadkari, Mahajan, Gelfand (CR60) 2017; 77 Augustin, Langenbruch, Blome, Gutknecht, Werfel, Ständer (CR31) 2020; 34 Arbabi, Zhand, Samadi, Ghaninejad, Golestan (CR5) 2009; 4 CY Wu (819_CR56) 2017; 12 JK Ostermann (819_CR81) 2015; 10 819_CR3 T Zuberbier (819_CR4) 2006; 118 E Civelek (819_CR64) 2011; 21 819_CR2 GH Guyatt (819_CR15) 2008; 336 L Misery (819_CR27) 2019; 33 R Launois (819_CR77) 2019; 33 SE Marron (819_CR11) 2020; 111 819_CR62 N Fukunaga (819_CR13) 2013; 77 A Mizara (819_CR63) 2012; 166 A Heratizadeh (819_CR41) 2020; 34 S Mina (819_CR54) 2015; 60 D Lei (819_CR37) 2020; 124 JK Ostermann (819_CR80) 2017; 12 T Bieber (819_CR95) 2022; 21 C Kim (819_CR76) 2014; 17 N Katoh (819_CR28) 2019; 46 JI Silverberg (819_CR52) 2020; 83 B Reed (819_CR97) 2018; 39 H van Os-Medendorp (819_CR46) 2015; 4 A Chee (819_CR32) 2020 G Shalom (819_CR70) 2019; 99 DK Lei (819_CR38) 2020; 183 L Eckert (819_CR71) 2018; 78 PH Le (819_CR83) 2019; 69 D Boehm (819_CR43) 2012; 67 H Norrlid (819_CR79) 2016; 96 MR Laughter (819_CR1) 2021; 184 S Ferrucci (819_CR36) 2020; 9 C Yano (819_CR91) 2013; 40 M Arbabi (819_CR5) 2009; 4 SH Yu (819_CR66) 2016; 27 PH Le (819_CR25) 2019; 69 A Langenbruch (819_CR65) 2014; 28 Y Lin (819_CR89) 2019; 22 FA Sorour (819_CR55) 2017; 14 W Wei (819_CR69) 2018; 45 K Ezzedine (819_CR92) 2020; 100 819_CR29 K Kaaz (819_CR45) 2019; 99 AM Drucker (819_CR75) 2018; 6 L Grant (819_CR16) 2019; 30 B Sheary (819_CR14) 2020; 31 H van Os-Medendorp (819_CR90) 2015; 4 J Ring (819_CR7) 2019; 33 L Eckert (819_CR61) 2019; 81 A Sicras-Mainar (819_CR74) 2018; 109 819_CR21 M Ameen (819_CR30) 2020; 23 819_CR20 L Andersen (819_CR94) 2020; 182 819_CR23 A Igarashi (819_CR51) 2019; 46 819_CR22 G Girolomoni (819_CR68) 2020; 11 RJ Silverwood (819_CR19) 2021; 147 819_CR17 L Väkevä (819_CR48) 2019; 35 LFM Ariëns (819_CR72) 2019; 99 C Avena-Woods (819_CR18) 2017; 23 M Schild (819_CR84) 2020; 23 L Eckert (819_CR60) 2017; 77 A Egeberg (819_CR57) 2017; 72 819_CR96 M Augustin (819_CR31) 2020; 34 Y Kwak (819_CR53) 2017; 31 V Joish (819_CR82) 2012; 15 W Wei (819_CR42) 2019; 123 SH Lee (819_CR26) 2018; 98 H Williams (819_CR6) 2008; 121 E Nettis (819_CR39) 2020; 32 SH Kim (819_CR58) 2015; 94 C Kim (819_CR88) 2015; 27 M Napolitano (819_CR47) 2020; 31 D Chrostowska-Plak (819_CR44) 2013; 27 JG Holm (819_CR49) 2016; 30 K Arima (819_CR59) 2018; 45 C Mann (819_CR9) 2020; 100 A Torrelo (819_CR93) 2012; 22 819_CR85 819_CR87 819_CR86 CJ Pedersen (819_CR10) 2021; 16 CJ Heckman (819_CR40) 2020; 140 J Whiteley (819_CR73) 2016; 32 B Falissard (819_CR33) 2020; 10 J Dieris-Hirche (819_CR50) 2017; 97 H Murota (819_CR78) 2020; 47 L Andersen (819_CR24) 2020; 182 X Wang (819_CR35) 2016; 2016 R Bobotsis (819_CR67) 2018; 22 B Devleesschauwer (819_CR8) 2014; 14 MJ Page (819_CR12) 2021; 372 MSY Ng (819_CR34) 2018; 59 |
References_xml | – ident: CR22 – volume: 46 start-page: 290 issue: 4 year: 2019 end-page: 300 ident: CR28 article-title: Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): baseline characteristics, treatment history and disease burden publication-title: J Dermatol contributor: fullname: Takagi – volume: 166 start-page: 986 issue: 5 year: 2012 end-page: 993 ident: CR63 article-title: Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease publication-title: Br J Dermatol contributor: fullname: McBride – volume: 78 start-page: 54 issue: 1 year: 2018 end-page: 61.e1 ident: CR71 article-title: The burden of atopic dermatitis in US adults: health care resource utilization data from the 2013 national health and wellness survey publication-title: J Am Acad Dermatol contributor: fullname: Gelfand – volume: 22 start-page: S376 year: 2019 ident: CR89 article-title: PSY11 Work productivity and activity impairment among patients with atopic dermatitis in Taiwan publication-title: Value Health contributor: fullname: Tang – volume: 28 start-page: 719 issue: 6 year: 2014 end-page: 726 ident: CR65 article-title: Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Augustin – volume: 4 start-page: 102 year: 2009 end-page: 106 ident: CR5 article-title: Psychiatric comorbidity and quality of life in patients with dermatologic diseases publication-title: Iran J Psychiatry contributor: fullname: Golestan – volume: 69 start-page: S49 issue: Suppl 2 year: 2019 end-page: S56 ident: CR25 article-title: Quality of life measurement alteration among Vietnamese: impact and treatment benefit related to eczema publication-title: J Pak Med Assoc. contributor: fullname: Nguyen – volume: 99 start-page: 175 issue: 2 year: 2019 end-page: 180 ident: CR45 article-title: Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis publication-title: Acta Derm Venereol contributor: fullname: Matusiak – volume: 10 issue: 7 year: 2015 ident: CR81 article-title: Can additional homeopathic treatment save costs? A retrospective cost-analysis based on 44500 insured persons publication-title: PLoS ONE. contributor: fullname: Witt – volume: 22 start-page: 97 issue: 1 year: 2012 end-page: 105 ident: CR93 article-title: Atopic dermatitis: impact on quality of life and patients' attitudes toward its management publication-title: Eur J Dermatol contributor: fullname: Cuervo – volume: 45 start-page: 150 issue: 2 year: 2018 end-page: 157 ident: CR69 article-title: Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis publication-title: J Dermatol contributor: fullname: Piercy – volume: 77 start-page: 1862 issue: 7 year: 2013 end-page: 1866 ident: CR13 article-title: Pay attention to valvular disease in the presence of atopic dermatitis publication-title: Circ J contributor: fullname: Koyama – volume: 46 start-page: 652 issue: 8 year: 2019 end-page: 661 ident: CR51 article-title: Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: a retrospective claims database analysis publication-title: J Dermatol contributor: fullname: Fukushima – volume: 97 start-page: 1189 issue: 10 year: 2017 end-page: 1195 ident: CR50 article-title: Suicidal ideation in adult patients with atopic dermatitis: a German cross-sectional study publication-title: Acta Derm Venereol contributor: fullname: Dieris – volume: 372 year: 2021 ident: CR12 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ contributor: fullname: Mulrow – volume: 4 issue: 2 year: 2015 ident: CR46 article-title: Usage and users of online self-management programs for adult patients with atopic dermatitis and food allergy: an explorative study publication-title: JMIR Res Protoc contributor: fullname: Knulst – volume: 69 start-page: S57 issue: 2 year: 2019 end-page: S63 ident: CR83 article-title: Economic burden and productivity loss related to eczema: a prevalence-based follow-up study in Vietnam publication-title: JPMA J Pak Med Assoc. contributor: fullname: Vo – ident: CR85 – volume: 23 start-page: S745 issue: s2 year: 2020 ident: CR30 article-title: The prevalence and clinical profile of atopic dermatitis (AD) in England—a population based linked cohort study using clinical practice research datalink (CPRD) and Hospital episode statistics (HES) publication-title: Value Health contributor: fullname: Millward – volume: 34 start-page: 1263 issue: 6 year: 2020 end-page: 1272 ident: CR41 article-title: Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREAT Germany publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Kleinheinz – volume: 109 start-page: 35 issue: 1 year: 2018 end-page: 46 ident: CR74 article-title: Economic impact of atopic dermatitis in adults: a population-based study (IDEA study) publication-title: Actas Dermo-Sifiliográficas (English Edn) contributor: fullname: Carrillo – volume: 47 start-page: 689 issue: 7 year: 2020 end-page: 698 ident: CR78 article-title: Cost of illness study for adult atopic dermatitis in Japan: a cross-sectional web-based survey publication-title: J Dermatol contributor: fullname: Ishimoto – volume: 96 start-page: 173 issue: 2 year: 2016 end-page: 176 ident: CR79 article-title: Cost-effectiveness of maintenance treatment with a barrier-strengthening moisturizing cream in patients with atopic dermatitis in Finland, Norway and Sweden publication-title: Acta Dermato-Venereol contributor: fullname: Ragnarson – volume: 9 start-page: 791 issue: 3 year: 2020 ident: CR36 article-title: Clinical response and quality of life in patients with severe atopic dermatitis treated with dupilumab: a single-center real-life experience publication-title: J Clin Med. contributor: fullname: Berti – volume: 21 start-page: 21 issue: 1 year: 2022 end-page: 40 ident: CR95 article-title: Atopic dermatitis: an expanding therapeutic pipeline for a complex disease publication-title: Nat Rev Drug Discov contributor: fullname: Bieber – volume: 17 start-page: A594 issue: 7 year: 2014 ident: CR76 article-title: The costs of illness of atopic dermatitis in South Korea publication-title: Value Health contributor: fullname: Choi – volume: 81 start-page: 187 issue: 1 year: 2019 end-page: 195 ident: CR61 article-title: Burden of illness in adults with atopic dermatitis: analysis of national health and wellness survey data from France, Germany, Italy, Spain, and the United Kingdom publication-title: J Am Acad Dermatol contributor: fullname: Gelfand – volume: 67 start-page: 184 issue: 4 year: 2012 end-page: 192 ident: CR43 article-title: Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema publication-title: Contact Dermatitis contributor: fullname: Werfel – volume: 100 start-page: 1 issue: 6 year: 2020 end-page: 6 ident: CR9 article-title: Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden publication-title: Acta Derm Venereol contributor: fullname: Staubach – ident: CR86 – volume: 118 start-page: 226 issue: 1 year: 2006 end-page: 232 ident: CR4 article-title: Patient perspectives on the management of atopic dermatitis publication-title: J Allergy Clin Immunol contributor: fullname: Hernanz-Hermosa – volume: 111 start-page: 513 issue: 6 year: 2020 end-page: 7 ident: CR11 article-title: Psychosocial impact of atopic dermatitis in adults: a qualitative study publication-title: Actas Dermosifiliogr (Engl Ed) contributor: fullname: Tomas-Aragones – volume: 147 start-page: 1753 issue: 5 year: 2021 end-page: 1763 ident: CR19 article-title: Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998–2016 publication-title: J Allergy Clin Immunol contributor: fullname: Roberts – volume: 72 start-page: 783 issue: 5 year: 2017 end-page: 791 ident: CR57 article-title: Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis publication-title: Allergy contributor: fullname: Thyssen – ident: CR3 – volume: 31 start-page: 316 issue: 5 year: 2020 end-page: 320 ident: CR14 article-title: Cessation of long-term topical steroids in adult atopic dermatitis: a prospective cohort study publication-title: Dermatitis contributor: fullname: Harris – volume: 182 start-page: 1176 issue: 5 year: 2020 end-page: 83 ident: CR24 article-title: Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A publication-title: Br J Dermatol. contributor: fullname: Nyberg – volume: 10 start-page: 297 issue: 2 year: 2020 end-page: 305 ident: CR33 article-title: Qualitative assessment of adult patients’ perception of atopic dermatitis using natural language processing analysis in a cross-sectional study publication-title: Dermatology and Therapy contributor: fullname: Gadkari – volume: 40 start-page: 736 issue: 9 year: 2013 end-page: 739 ident: CR91 article-title: Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis publication-title: J Dermatol contributor: fullname: Tofuku – volume: 59 start-page: e114 issue: 2 year: 2018 end-page: e117 ident: CR34 article-title: Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents publication-title: Australas J Dermatol contributor: fullname: Koh – volume: 60 start-page: 211 issue: 2 year: 2015 ident: CR54 article-title: Gender differences in depression and anxiety among atopic dermatitis patients publication-title: Indian J Dermatol contributor: fullname: Verma – volume: 123 start-page: 381 issue: 4 year: 2019 end-page: 8.e2 ident: CR42 article-title: A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): baseline treatment patterns and unmet needs assessment publication-title: Ann Allergy Asthma Immunol contributor: fullname: Kennedy – volume: 182 start-page: 1007 issue: 4 year: 2020 end-page: 1016 ident: CR94 article-title: Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the UK and the USA publication-title: Br J Dermatol contributor: fullname: Nyberg – volume: 11 start-page: 117 issue: 1 year: 2020 end-page: 130 ident: CR68 article-title: The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey publication-title: Dermatol Ther contributor: fullname: Llamado – volume: 77 start-page: 274 issue: 2 year: 2017 end-page: 9.e3 ident: CR60 article-title: Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey publication-title: J Am Acad Dermatol contributor: fullname: Gelfand – volume: 4 start-page: 535 issue: 4 year: 2015 end-page: 547 ident: CR90 article-title: Sick leave and factors influencing sick leave in adult patients with atopic dermatitis: a cross-sectional study publication-title: J Clin Med contributor: fullname: de Bruin-Weller – volume: 100 start-page: 00294 issue: 17 year: 2020 ident: CR92 article-title: Impact of atopic dermatitis in adolescents and their parents: a French study publication-title: Acta Dermato-Venereol contributor: fullname: Taïeb – volume: 27 start-page: 298 issue: 3 year: 2015 end-page: 305 ident: CR88 article-title: Economic impact of atopic dermatitis in Korean patients publication-title: Ann Dermatol contributor: fullname: Kim – volume: 14 start-page: 1196 year: 2014 ident: CR8 article-title: Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints publication-title: BMC Public Health contributor: fullname: Stein – volume: 27 start-page: e239 issue: 2 year: 2013 end-page: e242 ident: CR44 article-title: Relationship between itch and psychological status of patients with atopic dermatitis publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Szepietowski – volume: 12 issue: 2 year: 2017 ident: CR56 article-title: Osteoporosis in adult patients with atopic dermatitis: a nationwide population-based study publication-title: PLoS ONE contributor: fullname: Wu – ident: CR87 – volume: 32 start-page: 1645 issue: 10 year: 2016 end-page: 1651 ident: CR73 article-title: The burden of atopic dermatitis in US adults: results from the 2013 national health and wellness survey publication-title: Curr Med Res Opin contributor: fullname: Makinson – volume: 336 start-page: 924 issue: 7650 year: 2008 end-page: 926 ident: CR15 article-title: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ contributor: fullname: Alonso-Coello – ident: CR29 – volume: 121 start-page: 947 issue: 4 year: 2008 end-page: 54.e15 ident: CR6 article-title: Is eczema really on the increase worldwide? publication-title: J Allergy Clin Immunol contributor: fullname: Anderson – volume: 35 start-page: 332 issue: 5 year: 2019 end-page: 338 ident: CR48 article-title: Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: results from an observational multicenter study publication-title: Photodermatol Photoimmunol Photomed contributor: fullname: Hjerppe – ident: CR21 – year: 2020 ident: CR32 article-title: When life is an itch: What harms, helps, and heals from the patients' perspective? Differences and similarities among skin diseases publication-title: Dermatol Ther doi: 10.1111/dth.13606 contributor: fullname: Navarini – volume: 83 start-page: 1349 issue: 5 year: 2020 end-page: 1359 ident: CR52 article-title: Association of atopic dermatitis severity with cognitive function in adults publication-title: J Am Acad Dermatol contributor: fullname: Chopra – volume: 21 start-page: 270 issue: 4 year: 2011 end-page: 277 ident: CR64 article-title: Prevalence, burden, and risk factors of atopic eczema in schoolchildren aged 10–11 years: a national multicenter study publication-title: J Investig Allergol Clin Immunol contributor: fullname: Uner – volume: 23 start-page: S115 issue: 8 Suppl year: 2017 end-page: S123 ident: CR18 article-title: Overview of atopic dermatitis publication-title: Am J Manag Care contributor: fullname: Avena-Woods – volume: 33 start-page: 428 issue: 2 year: 2019 end-page: 432 ident: CR27 article-title: The impact of atopic dermatitis on sexual health publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Huet – volume: 14 start-page: 31 year: 2017 end-page: 36 ident: CR55 article-title: Psychiatric disorders associated with some chronic dermatologic diseases among a group of Egyptian dermatology outpatient clinic attendants publication-title: J Egypt Womens Dermatol Soc contributor: fullname: El Birqdar – ident: CR96 – volume: 30 start-page: 247 issue: 4 year: 2019 end-page: 254 ident: CR16 article-title: Conceptual model to illustrate the symptom experience and humanistic burden associated with atopic dermatitis in adults and adolescents publication-title: Dermatitis contributor: fullname: Simpson – volume: 183 start-page: 875 issue: 5 year: 2020 end-page: 882 ident: CR38 article-title: Validation of patient-reported outcomes information system sleep disturbance and sleep-related impairment in adults with atopic dermatitis publication-title: Br J Dermatol contributor: fullname: Sacotte – volume: 16 issue: 4 year: 2021 ident: CR10 article-title: Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families publication-title: PLoS ONE contributor: fullname: Darmstadt – volume: 22 start-page: 445 issue: 4 year: 2018 end-page: 446 ident: CR67 article-title: A Canadian adult cross-sectional survey of the burden of moderate to severe atopic dermatitis publication-title: J Cutan Med Surg contributor: fullname: Drucker – volume: 184 start-page: 304 issue: 2 year: 2021 end-page: 309 ident: CR1 article-title: The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017 publication-title: Br J Dermatol contributor: fullname: Langan – volume: 34 start-page: 142 issue: 1 year: 2020 end-page: 152 ident: CR31 article-title: Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Ständer – volume: 31 start-page: 516 issue: 5 year: 2017 end-page: 521 ident: CR53 article-title: Health-related quality of life and mental health of adults with atopic dermatitis publication-title: Arch Psychiatr Nurs contributor: fullname: Kim – volume: 32 start-page: 124 year: 2020 end-page: 132 ident: CR39 article-title: Use of dupilumab for 543 adult patients with moderate-to-severe atopic dermatitis: a multicenter, retrospective study publication-title: J Investig Allergol Clin Immunol. contributor: fullname: Di Leo – volume: 99 start-page: 762 issue: 9 year: 2019 end-page: 768 ident: CR72 article-title: Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment publication-title: Acta Derm Venereol contributor: fullname: Van Os-Medendorp – volume: 12 issue: 9 year: 2017 ident: CR80 article-title: A retrospective cost-analysis of additional homeopathic treatment in Germany: Longterm economic outcomes publication-title: PLoS ONE. contributor: fullname: Reinhold – volume: 27 start-page: 50 issue: 2 year: 2016 end-page: 58 ident: CR66 article-title: Burden of sleep and fatigue in US adults with atopic dermatitis publication-title: Dermatitis contributor: fullname: Silverberg – ident: CR2 – volume: 31 start-page: 81 issue: 1 year: 2020 end-page: 84 ident: CR47 article-title: Effectiveness of dupilumab for the treatment of generalized Prurigo nodularis phenotype of adult atopic dermatitis publication-title: Dermatitis contributor: fullname: Patruno – volume: 33 start-page: 1331 issue: 7 year: 2019 end-page: 1340 ident: CR7 article-title: Atopic eczema: burden of disease and individual suffering—results from a large EU study in adults publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Schielein – volume: 45 start-page: 390 issue: 4 year: 2018 end-page: 396 ident: CR59 article-title: Burden of atopic dermatitis in Japanese adults: analysis of data from the 2013 national health and wellness survey publication-title: J Dermatol contributor: fullname: Katayama – volume: 98 start-page: 89 issue: 1 year: 2018 end-page: 97 ident: CR26 article-title: Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea publication-title: Acta Derm Venereol contributor: fullname: Park – volume: 33 start-page: 1921 issue: 10 year: 2019 end-page: 1927 ident: CR77 article-title: Importance of out-of-pocket costs for adult patients with atopic dermatitis in France publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Heas – volume: 23 start-page: S745 issue: S2 year: 2020 ident: CR84 article-title: Healthcare resource utilization and associated costs among patients with atopic dermatitis—a retrospective cohort study based on German health claims DATA publication-title: Value Health contributor: fullname: Gothe – volume: 94 issue: 23 year: 2015 ident: CR58 article-title: Psychological distress in young adult males with atopic dermatitis: a cross-sectional study publication-title: Medicine (Baltimore) contributor: fullname: Son – volume: 2016 start-page: 2568301 year: 2016 ident: CR35 article-title: Prevalence and clinical features of atopic dermatitis in China publication-title: Biomed Res Int contributor: fullname: Shen – ident: CR23 – volume: 39 start-page: 406 issue: 6 year: 2018 end-page: 410 ident: CR97 article-title: The burden of atopic dermatitis publication-title: Allergy Asthma Proc contributor: fullname: Blaiss – volume: 124 start-page: 261 issue: 3 year: 2020 end-page: 266 ident: CR37 article-title: Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients publication-title: Ann Allergy Asthma Immunol contributor: fullname: Chavda – volume: 15 start-page: A521 issue: 7 year: 2012 ident: CR82 article-title: PHS18 economic burden of atopic dermatitis from a United States payer perspective publication-title: Value Health contributor: fullname: Eichenfield – volume: 99 start-page: 370 issue: 4 year: 2019 end-page: 374 ident: CR70 article-title: Healthcare service utilization by 116,816 patients with atopic dermatitis in Israel publication-title: Acta Dermato-Venereol contributor: fullname: Cohen – ident: CR17 – volume: 30 start-page: 1760 issue: 10 year: 2016 end-page: 1767 ident: CR49 article-title: Quality of life and disease severity in patients with atopic dermatitis publication-title: J Eur Acad Dermatol Venereol contributor: fullname: Thomsen – volume: 6 start-page: 1342 issue: 4 year: 2018 end-page: 1348 ident: CR75 article-title: Health care resource utilization and costs among adults with atopic dermatitis in the United States: a claims-based analysis publication-title: J Allergy Clin Immunol Pract contributor: fullname: Chao – ident: CR62 – ident: CR20 – volume: 140 start-page: 2138 issue: 11 year: 2020 end-page: 45.e1 ident: CR40 article-title: Development and initial psychometric properties of two itch-related measures: scratch intensity and impact, sleep-related itch and scratch publication-title: J Invest Dermatol contributor: fullname: Yosipovitch – volume: 2016 start-page: 2568301 year: 2016 ident: 819_CR35 publication-title: Biomed Res Int doi: 10.1155/2016/2568301 contributor: fullname: X Wang – volume: 12 issue: 2 year: 2017 ident: 819_CR56 publication-title: PLoS ONE doi: 10.1371/journal.pone.0171667 contributor: fullname: CY Wu – volume: 46 start-page: 652 issue: 8 year: 2019 ident: 819_CR51 publication-title: J Dermatol doi: 10.1111/1346-8138.14947 contributor: fullname: A Igarashi – volume: 77 start-page: 274 issue: 2 year: 2017 ident: 819_CR60 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2017.04.019 contributor: fullname: L Eckert – volume: 33 start-page: 428 issue: 2 year: 2019 ident: 819_CR27 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.15223 contributor: fullname: L Misery – volume: 27 start-page: 298 issue: 3 year: 2015 ident: 819_CR88 publication-title: Ann Dermatol doi: 10.5021/ad.2015.27.3.298 contributor: fullname: C Kim – volume: 98 start-page: 89 issue: 1 year: 2018 ident: 819_CR26 publication-title: Acta Derm Venereol doi: 10.2340/00015555-2797 contributor: fullname: SH Lee – volume: 4 start-page: 535 issue: 4 year: 2015 ident: 819_CR90 publication-title: J Clin Med doi: 10.3390/jcm4040535 contributor: fullname: H van Os-Medendorp – volume: 45 start-page: 150 issue: 2 year: 2018 ident: 819_CR69 publication-title: J Dermatol doi: 10.1111/1346-8138.14116 contributor: fullname: W Wei – ident: 819_CR21 – volume: 22 start-page: S376 year: 2019 ident: 819_CR89 publication-title: Value Health doi: 10.1016/j.jval.2019.04.1836 contributor: fullname: Y Lin – volume: 147 start-page: 1753 issue: 5 year: 2021 ident: 819_CR19 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2020.12.001 contributor: fullname: RJ Silverwood – volume: 4 start-page: 102 year: 2009 ident: 819_CR5 publication-title: Iran J Psychiatry contributor: fullname: M Arbabi – volume: 78 start-page: 54 issue: 1 year: 2018 ident: 819_CR71 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2017.08.002 contributor: fullname: L Eckert – ident: 819_CR96 – volume: 59 start-page: e114 issue: 2 year: 2018 ident: 819_CR34 publication-title: Australas J Dermatol doi: 10.1111/ajd.12632 contributor: fullname: MSY Ng – volume: 12 issue: 9 year: 2017 ident: 819_CR80 publication-title: PLoS ONE. doi: 10.1371/journal.pone.0182897 contributor: fullname: JK Ostermann – volume: 99 start-page: 370 issue: 4 year: 2019 ident: 819_CR70 publication-title: Acta Dermato-Venereol doi: 10.2340/00015555-3117 contributor: fullname: G Shalom – volume: 94 issue: 23 year: 2015 ident: 819_CR58 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000000949 contributor: fullname: SH Kim – ident: 819_CR2 – volume: 21 start-page: 21 issue: 1 year: 2022 ident: 819_CR95 publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-021-00266-6 contributor: fullname: T Bieber – ident: 819_CR85 – volume: 47 start-page: 689 issue: 7 year: 2020 ident: 819_CR78 publication-title: J Dermatol doi: 10.1111/1346-8138.15366 contributor: fullname: H Murota – ident: 819_CR29 – volume: 69 start-page: S49 issue: Suppl 2 year: 2019 ident: 819_CR25 publication-title: J Pak Med Assoc. contributor: fullname: PH Le – volume: 31 start-page: 516 issue: 5 year: 2017 ident: 819_CR53 publication-title: Arch Psychiatr Nurs doi: 10.1016/j.apnu.2017.06.001 contributor: fullname: Y Kwak – volume: 96 start-page: 173 issue: 2 year: 2016 ident: 819_CR79 publication-title: Acta Dermato-Venereol doi: 10.2340/00015555-2221 contributor: fullname: H Norrlid – volume: 33 start-page: 1331 issue: 7 year: 2019 ident: 819_CR7 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.15634 contributor: fullname: J Ring – volume: 4 issue: 2 year: 2015 ident: 819_CR46 publication-title: JMIR Res Protoc doi: 10.2196/resprot.4134 contributor: fullname: H van Os-Medendorp – volume: 69 start-page: S57 issue: 2 year: 2019 ident: 819_CR83 publication-title: JPMA J Pak Med Assoc. contributor: fullname: PH Le – ident: 819_CR22 – volume: 46 start-page: 290 issue: 4 year: 2019 ident: 819_CR28 publication-title: J Dermatol doi: 10.1111/1346-8138.14787 contributor: fullname: N Katoh – volume: 109 start-page: 35 issue: 1 year: 2018 ident: 819_CR74 publication-title: Actas Dermo-Sifiliográficas (English Edn) contributor: fullname: A Sicras-Mainar – volume: 336 start-page: 924 issue: 7650 year: 2008 ident: 819_CR15 publication-title: BMJ doi: 10.1136/bmj.39489.470347.AD contributor: fullname: GH Guyatt – volume: 39 start-page: 406 issue: 6 year: 2018 ident: 819_CR97 publication-title: Allergy Asthma Proc doi: 10.2500/aap.2018.39.4175 contributor: fullname: B Reed – volume: 97 start-page: 1189 issue: 10 year: 2017 ident: 819_CR50 publication-title: Acta Derm Venereol doi: 10.2340/00015555-2741 contributor: fullname: J Dieris-Hirche – volume: 182 start-page: 1176 issue: 5 year: 2020 ident: 819_CR24 publication-title: Br J Dermatol. doi: 10.1111/bjd.18451 contributor: fullname: L Andersen – volume: 30 start-page: 1760 issue: 10 year: 2016 ident: 819_CR49 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.13689 contributor: fullname: JG Holm – volume: 166 start-page: 986 issue: 5 year: 2012 ident: 819_CR63 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2011.10799.x contributor: fullname: A Mizara – volume: 28 start-page: 719 issue: 6 year: 2014 ident: 819_CR65 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.12154 contributor: fullname: A Langenbruch – volume: 11 start-page: 117 issue: 1 year: 2020 ident: 819_CR68 publication-title: Dermatol Ther doi: 10.1007/s13555-020-00459-8 contributor: fullname: G Girolomoni – volume: 100 start-page: 1 issue: 6 year: 2020 ident: 819_CR9 publication-title: Acta Derm Venereol doi: 10.2340/00015555-3416 contributor: fullname: C Mann – volume: 23 start-page: S115 issue: 8 Suppl year: 2017 ident: 819_CR18 publication-title: Am J Manag Care contributor: fullname: C Avena-Woods – volume: 10 start-page: 297 issue: 2 year: 2020 ident: 819_CR33 publication-title: Dermatology and Therapy doi: 10.1007/s13555-020-00356-0 contributor: fullname: B Falissard – volume: 22 start-page: 97 issue: 1 year: 2012 ident: 819_CR93 publication-title: Eur J Dermatol doi: 10.1684/ejd.2011.1560 contributor: fullname: A Torrelo – volume: 99 start-page: 175 issue: 2 year: 2019 ident: 819_CR45 publication-title: Acta Derm Venereol doi: 10.2340/00015555-3065 contributor: fullname: K Kaaz – volume: 34 start-page: 1263 issue: 6 year: 2020 ident: 819_CR41 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.16078 contributor: fullname: A Heratizadeh – volume: 17 start-page: A594 issue: 7 year: 2014 ident: 819_CR76 publication-title: Value Health doi: 10.1016/j.jval.2014.08.2042 contributor: fullname: C Kim – ident: 819_CR3 – volume: 111 start-page: 513 issue: 6 year: 2020 ident: 819_CR11 publication-title: Actas Dermosifiliogr (Engl Ed) doi: 10.1016/j.ad.2019.03.018 contributor: fullname: SE Marron – volume: 77 start-page: 1862 issue: 7 year: 2013 ident: 819_CR13 publication-title: Circ J doi: 10.1253/circj.CJ-12-1371 contributor: fullname: N Fukunaga – volume: 22 start-page: 445 issue: 4 year: 2018 ident: 819_CR67 publication-title: J Cutan Med Surg doi: 10.1177/1203475418758992 contributor: fullname: R Bobotsis – ident: 819_CR86 – volume: 67 start-page: 184 issue: 4 year: 2012 ident: 819_CR43 publication-title: Contact Dermatitis doi: 10.1111/j.1600-0536.2012.02062.x contributor: fullname: D Boehm – volume: 123 start-page: 381 issue: 4 year: 2019 ident: 819_CR42 publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2019.07.008 contributor: fullname: W Wei – volume: 60 start-page: 211 issue: 2 year: 2015 ident: 819_CR54 publication-title: Indian J Dermatol contributor: fullname: S Mina – volume: 23 start-page: S745 issue: S2 year: 2020 ident: 819_CR84 publication-title: Value Health doi: 10.1016/j.jval.2020.08.2024 contributor: fullname: M Schild – volume: 72 start-page: 783 issue: 5 year: 2017 ident: 819_CR57 publication-title: Allergy doi: 10.1111/all.13085 contributor: fullname: A Egeberg – volume: 45 start-page: 390 issue: 4 year: 2018 ident: 819_CR59 publication-title: J Dermatol doi: 10.1111/1346-8138.14218 contributor: fullname: K Arima – volume: 100 start-page: 00294 issue: 17 year: 2020 ident: 819_CR92 publication-title: Acta Dermato-Venereol doi: 10.2340/00015555-3653 contributor: fullname: K Ezzedine – volume: 35 start-page: 332 issue: 5 year: 2019 ident: 819_CR48 publication-title: Photodermatol Photoimmunol Photomed doi: 10.1111/phpp.12479 contributor: fullname: L Väkevä – volume: 15 start-page: A521 issue: 7 year: 2012 ident: 819_CR82 publication-title: Value Health doi: 10.1016/j.jval.2012.08.1791 contributor: fullname: V Joish – volume: 99 start-page: 762 issue: 9 year: 2019 ident: 819_CR72 publication-title: Acta Derm Venereol doi: 10.2340/00015555-3212 contributor: fullname: LFM Ariëns – volume: 183 start-page: 875 issue: 5 year: 2020 ident: 819_CR38 publication-title: Br J Dermatol doi: 10.1111/bjd.18920 contributor: fullname: DK Lei – year: 2020 ident: 819_CR32 publication-title: Dermatol Ther doi: 10.1111/dth.13606 contributor: fullname: A Chee – volume: 27 start-page: e239 issue: 2 year: 2013 ident: 819_CR44 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2012.04578.x contributor: fullname: D Chrostowska-Plak – volume: 31 start-page: 81 issue: 1 year: 2020 ident: 819_CR47 publication-title: Dermatitis doi: 10.1097/DER.0000000000000517 contributor: fullname: M Napolitano – volume: 30 start-page: 247 issue: 4 year: 2019 ident: 819_CR16 publication-title: Dermatitis doi: 10.1097/DER.0000000000000486 contributor: fullname: L Grant – volume: 140 start-page: 2138 issue: 11 year: 2020 ident: 819_CR40 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2020.03.961 contributor: fullname: CJ Heckman – volume: 40 start-page: 736 issue: 9 year: 2013 ident: 819_CR91 publication-title: J Dermatol doi: 10.1111/1346-8138.12220 contributor: fullname: C Yano – volume: 34 start-page: 142 issue: 1 year: 2020 ident: 819_CR31 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.15919 contributor: fullname: M Augustin – volume: 121 start-page: 947 issue: 4 year: 2008 ident: 819_CR6 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2007.11.004 contributor: fullname: H Williams – volume: 32 start-page: 1645 issue: 10 year: 2016 ident: 819_CR73 publication-title: Curr Med Res Opin doi: 10.1080/03007995.2016.1195733 contributor: fullname: J Whiteley – ident: 819_CR62 doi: 10.1145/3025453.3025569 – volume: 21 start-page: 270 issue: 4 year: 2011 ident: 819_CR64 publication-title: J Investig Allergol Clin Immunol contributor: fullname: E Civelek – volume: 184 start-page: 304 issue: 2 year: 2021 ident: 819_CR1 publication-title: Br J Dermatol doi: 10.1111/bjd.19580 contributor: fullname: MR Laughter – volume: 6 start-page: 1342 issue: 4 year: 2018 ident: 819_CR75 publication-title: J Allergy Clin Immunol Pract doi: 10.1016/j.jaip.2017.10.024 contributor: fullname: AM Drucker – volume: 118 start-page: 226 issue: 1 year: 2006 ident: 819_CR4 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2006.02.031 contributor: fullname: T Zuberbier – volume: 31 start-page: 316 issue: 5 year: 2020 ident: 819_CR14 publication-title: Dermatitis doi: 10.1097/DER.0000000000000602 contributor: fullname: B Sheary – volume: 16 issue: 4 year: 2021 ident: 819_CR10 publication-title: PLoS ONE doi: 10.1371/journal.pone.0249824 contributor: fullname: CJ Pedersen – volume: 182 start-page: 1007 issue: 4 year: 2020 ident: 819_CR94 publication-title: Br J Dermatol doi: 10.1111/bjd.18296 contributor: fullname: L Andersen – volume: 124 start-page: 261 issue: 3 year: 2020 ident: 819_CR37 publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2019.12.002 contributor: fullname: D Lei – volume: 32 start-page: 124 year: 2020 ident: 819_CR39 publication-title: J Investig Allergol Clin Immunol. doi: 10.18176/jiaci.0641 contributor: fullname: E Nettis – volume: 14 start-page: 31 year: 2017 ident: 819_CR55 publication-title: J Egypt Womens Dermatol Soc doi: 10.1097/01.EWX.0000503397.22746.bd contributor: fullname: FA Sorour – volume: 83 start-page: 1349 issue: 5 year: 2020 ident: 819_CR52 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2020.05.041 contributor: fullname: JI Silverberg – ident: 819_CR87 – ident: 819_CR23 – volume: 372 year: 2021 ident: 819_CR12 publication-title: BMJ doi: 10.1136/bmj.n71 contributor: fullname: MJ Page – volume: 9 start-page: 791 issue: 3 year: 2020 ident: 819_CR36 publication-title: J Clin Med. doi: 10.3390/jcm9030791 contributor: fullname: S Ferrucci – volume: 27 start-page: 50 issue: 2 year: 2016 ident: 819_CR66 publication-title: Dermatitis doi: 10.1097/DER.0000000000000161 contributor: fullname: SH Yu – ident: 819_CR20 – volume: 23 start-page: S745 issue: s2 year: 2020 ident: 819_CR30 publication-title: Value Health doi: 10.1016/j.jval.2020.08.2025 contributor: fullname: M Ameen – volume: 14 start-page: 1196 year: 2014 ident: 819_CR8 publication-title: BMC Public Health doi: 10.1186/1471-2458-14-1196 contributor: fullname: B Devleesschauwer – volume: 10 issue: 7 year: 2015 ident: 819_CR81 publication-title: PLoS ONE. doi: 10.1371/journal.pone.0134657 contributor: fullname: JK Ostermann – volume: 33 start-page: 1921 issue: 10 year: 2019 ident: 819_CR77 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/jdv.15581 contributor: fullname: R Launois – ident: 819_CR17 – volume: 81 start-page: 187 issue: 1 year: 2019 ident: 819_CR61 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.03.037 contributor: fullname: L Eckert |
SSID | ssj0000706381 |
Score | 2.460662 |
SecondaryResourceType | review_article |
Snippet | Introduction
Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is... Introduction Although previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is... Although previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated... INTRODUCTIONAlthough previously regarded as a children's disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not... Atopic dermatitis is a very common skin disease among children and adults. The disease is nonfatal but may lead to patients and families having a low quality... |
SourceID | pubmedcentral proquest gale crossref springer |
SourceType | Open Access Repository Aggregation Database Publisher |
StartPage | 2653 |
SubjectTerms | Atopic dermatitis Care and treatment Complications and side effects Dermatology Economic aspects Internal Medicine Medicine Medicine & Public Health Oral and Maxillofacial Surgery Plastic Surgery Quality of Life Research Review |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JSsRAEC1cQLyIK44bLQgeNNLpZLIIIsEFEfWiA96a9IYDklFnBP17q7LMEBXBSy4dsryq7npFV70G2AuM0IETmKbGJsAEJc293DrnpcpigOoGudLUKHx7F131wuvH7uMUNMcd1QAOf03t6Dyp3tvz0cfr5ylO-JNJGxwGTeozFl4Z4bxoGmZFiJk6lfLVdL9cmWMK0JSD4TwNvATTnbqP5vfHtGLV9xX7ZxXlt63UMkJdLsJCTS1ZVvnCEkzZYhnmbuvN8xXoVS0LbOBYNhq89DU7txVh7Q9Zv2AZSXEMWV4Ylk10no5Zzu7Hcs_sZizDzKpthVXoXV48nF159akKng5TPkJ7xE6EKnDG6piH2hdI0mKnfd3FYKYCbZRJtLBppHzLE4t8wfkm5Qa5TJTgdQ1mikFh14FZFQrbVVEY5y7keZBwlxjf14ZrHplYd-CgwU--VOIZciKTTGhLRFuWaMuoA_sEsSRbI6A6rxsE8F2kUSUzpFpIEEXKO7DVuhNnhG4N7zZGkjREZWSFHbwPpSCpIqRkftqBuGW98feR3HZ7pOg_lbLbKZ3L4uNnHjZ2lo27_vFXG__CYBPmBTlgWS-zBTOjt3e7jaxnpHZKV_4Cq7H65g priority: 102 providerName: Scholars Portal – databaseName: Springer Open Access Hybrid - NESLI2 2011-2012 dbid: 40G link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA66gngRn1hdJYLgQQtp-vZW1HUR14sueAvNC_fSLrb7_530SVcRvPSS0MfMJPNNZ-YLQleupMLVFMLUULoQoMSpnSqt7ZgrcFC-m3JhGoVnr8F07j1_-B99H3dV7N5mJKuNuu91A89omompXbkxO9hEW-B7iIm4PPLU_VgBGwabMoEWLEbXjmBK0yzz-20GDml9W_5ZKrmWL63c0GQP7Tb4ESe1wvfRhsoO0PasyZAfonndl4BzjZMyXy4EflA1Kl0UeJHhxPBtFDjNJE56Mqc7nOK3jtMZv3Rcy7jOHRyh-eTx_X5qN0cn2MKLSQlCDzX1uKulEiHxhEMBiYVaOMIHj8VdIbmMBFVxwB1FIgWgQDsyJhIASxDB9RiNsjxTJwgr7lHl88ALU-2R1I2IjqTjCEkECWQoLHTTyo8ta4YM1nMhG2kzkDarpM0CC10bETOzfECgIm26AOBZhoiKJYCnAAXSmFhoPJgJZi8Gw5etkpgZMrVimcpXBaOGjwhwlxNbKBxor3s_w6k9HMkWnxW3dmwOX3HgNW9bPbNmURd_fNXp_6afoR1qLLCqihmjUfm1UueAbUp-UdnyNxtc8D8 priority: 102 providerName: Springer Nature |
Title | Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review |
URI | https://link.springer.com/article/10.1007/s13555-022-00819-6 https://search.proquest.com/docview/2721639919 https://pubmed.ncbi.nlm.nih.gov/PMC9674816 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB51e0BcEE8RKCsjIXGAdB3beZhbtFAqxCIkWKk3K36JSDS7Yrf_n7GTbJtW4sBlLo7kZDzj-Sae-QzwhltmuGeYppaWY4Iim7Rx3qdSOwxQOW-0CY3Cq2_F-Vp8ucgvjiAfe2Fi0b7R7Wn3-_K0a3_F2srtpVmMdWKL76ulDDdkZMViBjM00Bspetx-yxCFQ6KFzsjTCnOaoVmmb5nDABt6klkao2Ea7jDimEUgbpaT2HR7h75bNXnr6DRGpLOH8GCAkqTuX_kRHLnuMdxbDYflT2DdtyiQjSf1frNtDfnoeoDa7kjbkTpQb-xI01lSX_M6fSAN-XGgdyZfD7TLpD9GeArrs08_l-fpcItCaoSke9R_6ZnQ3FtnSipMxhCUld5kJsfgpbmx2laGOVnozNHKIT7wmZXUInYpKpTP4LjbdO45EKcFc7kuRNl4QRteUV_ZLDOWGlrY0iTwbtSf2vZkGeqaFjkoXqHiVVS8KhJ4G1SsgiehQk0zNATgXIGTStUIrRAQMkkTOJk8iR5gJsOvx0VSYSiUjXVuc7VTLFATIQTLZALlZPUO7xfotacjaHWRZnuwsgTej-usBv_e_eOrXvz3RC_hPgt2GWtlTuB4_-fKvULEs9dzmAn6GeWSiSCL5Tz-O0C5EtU82j_KNav_AuQfAk0 |
link.rule.ids | 230,315,730,783,787,867,888,2228,24330,27936,27937,40913,41131,41132,41535,41982,42200,42201,42604,51588,52107,52245,52246,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SBNpeQvoiTtJUhUAOrbOy_FRvJg827W4oNAu5CetFDY136W7-f0ayvYkT6KEXX2SQNA_NN2jmE8BRrJmKLcM0NdcxJii8CitjbcilwQCVxpVUrlF4epWNZ8n3m_RmA9K-F8YX7StZnzR_bk-a-revrVzcqlFfJzb6OT3l7oWMKBu9gC30V5o8StL9AZy7OOxSLXTHOCwwq-naZdqmOQyxriuZhT4ehu4VoxjzCETOfBCdnp7Rz-smn1ye-ph0sQPbHZgkZbvoN7Bhmrfwctpdl7-DWdukQOaWlKv5olbkzLQQtV6SuiGlI99YkqrRpHxgdvpGKvJrTfBMJmviZdJeJLyH2cX59ek47N5RCFXC6Qo1kFuWyNhqo3KaqIghLMutilSK4UvGSktdKGZ4JiNDC4MIwUaaU43oJSvw-wE2m3ljdoEYmTCTyizJK5vQCoVvCx1FSlNFM52rAL708hOLli5DPBAjO8ELFLzwghdZAMdOxML5EgpUVV1LAM7lWKlEieAKISHjNICDwZ_oA2ow_LlXknBDrnCsMfO7pWCOnAhBWMQDyAfaW6_PEWwPR9DuPNF2Z2cBfO31LDoPX_5jV3v_PdEneDW-nk7E5PLqxz68Zs5GfeXMAWyu_t6Zj4h_VvLQW_s9dm8AeA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9RAEB5qC8UXsVUxWusKBR80vc0ml2R9C61Ha3uloAd9W7KzuxiwucO7_v_ObnLXpoIPvuRlA5vMj51v2JlvAI5SIzB1gtLUwqSUoMg6rq1zsdSWAtQ4rTX6RuHpVX42y77djG8ejPoKRfuom-P21-1x2_wMtZWLWxyt68RG19MT6SdkJPloYdzoCeyQz_L8QaIeDuHCx2KfbpFLpnFJmU3fMtM1zlGY9Z3JIg4xMfaTjFLKJQg9y0GEenxO_107-egCNcSlyXN41gNKVnUfvgdbtt2H3Wl_Zf4CZl2jAps7Vq3miwbZqe1garNkTcsqT8CxZHVrWHXP7vSF1ez7huSZXW7Il1l3mfASZpOvP07O4n6WQoyZ5CvSQuFEplNnLBY8w0QQNCscJjimEKZTNNqUKKzMdWJ5aQkluMRIbgjB5CU9X8F2O2_ta2BWZ8KOdZ4Vtct4TcJ3pUkSNBx5bgqM4NNafmrRUWaoe3JkL3hFgldB8CqP4KMXsfL-RALFum8LoL08M5WqCGARLBSSR3AweJP8AAfLH9ZKUn7JF4-1dn63VMITFBEQS2QExUB7m-_zJNvDFbK9QLbd21oEn9d6Vr2XL__xV2_-e6P3sHt9OlGX51cXb-Gp8CYaimcOYHv1-86-Iwi00ofB2P8AODYBiw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Burden+of+Atopic+Dermatitis+in+Adults+and+Adolescents%3A+a+Systematic+Literature+Review&rft.jtitle=Dermatology+and+therapy&rft.au=Fasseeh%2C+Ahmad+N.&rft.au=Elezbawy%2C+Baher&rft.au=Korra%2C+Nada&rft.au=Tannira%2C+Mohamed&rft.date=2022-12-01&rft.issn=2193-8210&rft.eissn=2190-9172&rft.volume=12&rft.issue=12&rft.spage=2653&rft.epage=2668&rft_id=info:doi/10.1007%2Fs13555-022-00819-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13555_022_00819_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2193-8210&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2193-8210&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2193-8210&client=summon |